Article Information
PubMed
Published By
History
- Received August 13, 2007
- Revision received November 13, 2007
- Accepted November 14, 2007
- First published December 19, 2007.
- Version of record published December 19, 2007.
Copyright & Usage
Copyright © 2007 Society for Neuroscience 0270-6474/07/2714158-13$15.00/0
Author Information
- 1Department of Neuroscience and Center for Molecular Neurobiology,
- 2Neuroscience Graduate Studies Program, and
- 3Biophysics Graduate Program, The Ohio State University, Columbus, Ohio 43210
- Correspondence should be addressed to Dr. Chen Gu, 182 Rightmire Hall, 1060 Carmack Road, The Ohio State University, Columbus, OH 43210. gu.49{at}osu.edu
Author contributions
Disclosures
- Received August 13, 2007.
- Revision received November 13, 2007.
- Accepted November 14, 2007.
-
This work was supported by a Career Transition Fellowship Award (C.G.) from the National Multiple Sclerosis Society (Grant TA3012A1) and an Ohio State University startup fund (C.G.). Additional support was provided by National Institutes of Health Grant P30-NS045758. We thank Dr. B. Rudy for Kv3.1a and Kv3.1b cDNA constructs; Drs. V. Bennett and L. Isom for ankyrin G-GFP and polyclonal anti-ankyrin G antibody; Dr. G. Banker for transferrin receptor-GFP; Dr. S. Qin for technical assistance; and Drs. L. Y. Jan, V. Bennett, A. P. Young, and J. Oberdick for valuable comments on this manuscript.
- Correspondence should be addressed to Dr. Chen Gu, 182 Rightmire Hall, 1060 Carmack Road, The Ohio State University, Columbus, OH 43210. gu.49{at}osu.edu
Online Impact